Other languages Shattuck Labs, Inc.

Equities

STTK

US82024L1035

Market Closed - Nasdaq Other stock markets 02:00:00 04/05/2024 am IST			5-day change	1st Jan Change
10.78 ^USD	-2.88%		+1.79%	+51.19%

02/05	Shattuck Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04/03	Shattuck Labs, Inc. Announces Board Appointments	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shattuck Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Shattuck Labs, Inc. Announces Board Appointments	04/03
Sector Update: Health Care Stocks Rising Late Afternoon	02/03
Sector Update: Health Care Stocks Advance Friday Afternoon	02/03
Shattuck Labs Shares Rise as Q4 Net Loss Narrows	01/03
Shattuck Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/03
Shattuck Labs, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01/03
Shattuck Labs Collaborates With Ono Pharmaceutical to Develop Fusion Proteins	14/02
Shattuck Labs, Inc. Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases	13/02
Shattuck Labs Insider Sold Shares Worth $250,000, According to a Recent SEC Filing	17/01
Shattuck Labs, Inc. Files Initial Topline Dose-Exp Expansion Data from Its Ongoing Phase 1A/B Clinical Trial of Sl-172154 in Frontline Tp53m Aml and Tp53m Aml Patients	21/12
Shattuck Labs Shares Soar as Blood Cancer Therapy Trial Yields 79% Objective Response Rate	14/12
Top Midday Gainers	14/12
Fed Meeting Awaited as Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Wednesday	13/12
Top Premarket Gainers	13/12
Shattuck Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Shattuck Labs, Inc. to Present Topline Data from Phase 1 A/B Clinical Trial of Sl-172154 in Relapsed/Refractory (R/R) Acute Myeloid Leukemia and Higher-Mds) Patients At the American Society of Hematology 2023 Annual Meeting	02/11
Shattuck Labs, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11
Shattuck Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	10/23/10
Shattuck Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	24/23/24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Shattuck Labs, Inc.

Equities

STTK

US82024L1035

Other languages

Filters